Author name: admin

Uncategorized

New Releases from NCBI BookshelfWHO guideline on HIV service delivery: Updated guidance on the integration of diabetes, hypertension and mental health services, and interventions to support adherence to antiretroviral therapy [Internet].​WHO guideline on HIV service delivery: Updated guidance on the integration of diabetes, hypertension and mental health services, and interventions to support adherence to antiretroviral therapy [Internet].

This WHO guideline recommends integrating services for hypertension, diabetes, and mental health (including depression, anxiety, and substance use) into HIV […]

Uncategorized

New Releases from NCBI BookshelfDupilumab (Dupixent): Indication: For the treatment of adult patients with moderate-to-severe prurigo nodularis (PN) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent can be used with or without topical corticosteroids: Reimbursement Recommendation [Internet].​Dupilumab (Dupixent): Indication: For the treatment of adult patients with moderate-to-severe prurigo nodularis (PN) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent can be used with or without topical corticosteroids: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Dupixent be reimbursed by public drug plans for the treatment of adult patients with

Uncategorized

New Releases from NCBI BookshelfDurvalumab (Imfinzi): Indication: As monotherapy, for the treatment of adult patients with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy: Reimbursement Recommendation [Internet].​Durvalumab (Imfinzi): Indication: As monotherapy, for the treatment of adult patients with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Imfinzi be reimbursed by public drug plans for the treatment of adults with limited-stage

Scroll to Top